Related Experiment Video
Updated: Oct 4, 2026

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
Published on: July 25, 2013
Multi-Objective-Conditioned-Return-Blocks Decision Transformer: A Novel Approach for Multi-Objective De Novo Drug
Eyal Mazuz1, Or Gindes1, Lior Rokach1
1Faculty of Computer and Information Sciences, Ben-Gurion University of the Negev, David Ben Gurion Blvd, 8410501, Be'er Sheva, Israel.
Motivation:
Designing novel molecules that simultaneously satisfy several, often conflicting, properties is a long-standing challenge in drug design. While recent deep learning advances optimize single targets effectively, navigating the trade-offs required for multiple objectives remains a difficult problem.
Results:
We introduce the Multi-Objective-Conditioned-Return-Blocks Decision Transformer (M-GoRT), a novel architecture for multi-target de-novo drug design incorporating return-to-go blocks conditioned on goal embeddings. Trained without exploration, reward weighting or online fine-tuning, M-GoRT efficiently optimizes for multiple targets. M-GoRT achieves competitive multi-objective success rates against state-of-the-art baselines while maintaining superior structural diversity and novelty, even in high-dimensional tasks incorporating biological targets (DRD2, JNK3). In these high-dimensional tasks, M-GoRT maintains superior structural diversity and novelty establishing it as a practical tool for multi-property molecular generation.
Availability And Implementation:
M-GoRT is freely available as an open-source software under the MIT license at GitHub https://github.com/eyalmazuz/MolGen/tree/GCRB-DT.
Contact:
For further information, please contact mazuze@post.bgu.ac.il.
Supplementary Information:
Supplementary data associated with this research are available at Bioinformatics online.
Related Concept Videos
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Drug Discovery: Overview
Pharmacogenomics: Identification of New Drug Targets
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Drug Biotransformation: Overview
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs